MDM2 and breast cancer: We demonstrated that the MDM2-overexpressing and MDM2-knockdown cells were less sensitive to the compound, showing resistance to apoptosis and cell cycle arrest, thus supporting the importance of MDM2 inhibition in the anti-breast cancer activities of 25-OCH3-PPD.